AI-Powered Multi-Omics Revolutionizes Natural Product Drug Discovery

Natural products have historically been goldmines for drug discovery, but traditional screening methods are painfully slow and often hit dead ends. This comprehensive review reveals how cutting-edge multi-omics approaches are transforming this ancient field into a high-tech powerhouse.

Researchers are now integrating metabolomics, genomics, transcriptomics, and proteomics with sophisticated computational tools. Advanced platforms like high-resolution LC-MS/MS and Global Natural Products Social molecular networking enable comprehensive compound profiling, while genome mining tools like antiSMASH and DeepBGC rapidly identify biosynthetic gene clusters in both cultured and mysterious uncultured organisms.

The real game-changer is artificial intelligence integration. Machine learning algorithms are constructing gene-metabolite correlation networks and leveraging knowledge graphs to predict compound functions and therapeutic potential. Chemoproteomics techniques like thermal proteome profiling are revealing how these compounds actually work at the molecular level.

This technological convergence promises to dramatically accelerate the timeline from natural source identification to therapeutic development. Instead of years of trial-and-error screening, researchers can now use predictive models to identify the most promising compounds and understand their mechanisms before expensive laboratory validation.

The implications extend beyond pharmaceuticals to nutraceuticals and longevity compounds, potentially unlocking nature's vast chemical library for human healthspan extension.